Journal Guide

Journal of the Egyptian National Cancer Institute aims at publishing articles related to all fields of cancer in order to disperse up-to-date information to all medical personnel interested in this field.

Scope:

Journal of the Egyptian National Cancer Institute publishes original articles related to all fields of cancer, including basic, applied, and clinical cancer research.

The Journal of the National Cancer Institute (print ISSN: 0027-8874, online ISSN: 1460-2105) publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.JNCI is indexed and abstracted by the following:Abstracts on Hygiene and Communicable DiseasesAgbiotech News and InformationAmerican Statistics IndexAnnals of Behavioral MedicineAbstracts in AnthropologyBiological AbstractsBIOSIS PreviewsCAB AbstractsCINAHLCSA Oncogenes and Growth Factor AbstractsCurrent Contents® /Clinical MedicineCurrent Contents® /Life SciencesDairy Science AbstractsDerwent Drug FileElsevier BIOBASE - Current Awareness in Biological Sciences (CABS)Environmental Science and Pollution ManagementExcerpta Medica Abstract JournalsFood Science and Technology AbstractsGlobal HealthHealth & Safety Science AbstractsIDISINIS AtomindexInternational Pharmaceutical AbstractsJournal Citation Reports /Science EditionNutrition Abstracts and ReviewsNutrition Research NewsletterOncology information servicePharmacoeconomics and Outcome NewsPROQUEST DATABASE : MagazinesPROQUEST DATABASE : MEDLINE with Full TextPROQUEST DATABASE : ProQuest 5000PROQUEST DATABASE : ProQuest 5000 InternationalPROQUEST DATABASE : ProQuest Biology JournalsPROQUEST DATABASE : ProQuest CentralPROQUEST DATABASE : ProQuest DiscoveryPROQUEST DATABASE : ProQuest Family HealthPROQUEST DATABASE : ProQuest Health & Medical CompletePROQUEST DATABASE : ProQuest International Academic Research LibraryPROQUEST DATABASE : ProQuest Medical LibraryPROQUEST DATABASE : ProQuest News & MagazinesPROQUEST DATABASE : ProQuest Nursing & Allied Health SourcePROQUEST DATABASE : ProQuest Pharma CollectionPROQUEST DATABASE : ProQuest PlatinumPROQUEST DATABASE : ProQuest Research LibraryPubMedProus Science Integrity®Reactions WeeklyReview of Aromatic and Medicinal PlantsReview of Medical and Veterinary MycologyRisk AbstractsRural Development AbstractsSage Race Relations AbstractsScience Citation Index Expanded (SciSearch®)Science Citation Index®Soybean AbstractsThe Standard Periodical DirectoryToxicology AbstractsTropical Diseases BulletinWeed AbstractsJNCI is published twice monthly by Oxford University Press and is not affiliated with the United States National Cancer Institute. .

Leukemia covers all aspects of the research and treatment of Leukemia and Allied Diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more.Impact Factor2010 Impact Factor: 8.966*Rank:4/65 Hematology10/184 Oncology*2010 Journal Citation Reports (Thomson Reuters, 2011)Abstracted/indexed inBIOBASE/Current Awareness in Biological SciencesBIOSISCambridge Scientific AbstractsCurrent Advances in Cell and Developmental BiologyCurrent Advances in Genetics and Molecular BiologyCurrent ContentsCurrent Contents/Life SciencesEMBASE/Excerpta MedicaMEDLINE/Index MedicusResearch AlertReference UpdateScience Citation IndexScience Citation Index ExpandedSUBISISSN and eISSNThe international standard serial number (ISSN) for Leukemia is 0887-6924, and the electronic international standard serial number (eISSN) is 1476-5551.

Leukemia & Lymphoma is an international journal that publishes full-length papers and reviews on clinical and therapeutic practice, epidemiological studies and outcomes analysis, laboratory diagnosis, pathology, cytology, ultrastructure, cytogenetics and cellular and molecular immunology of hematologic malignancies; the journal aims at a strong clinical-pathologic correlation. Letters and correspondence to the editors are also accepted on all topics, which are novel and provide new and interesting data for clinicians and postgraduate teaching. In addition, an update is provided on the basic issues and advances in molecular genetics as applied to this field. The journal will provide an important reference source for physicians and scientists who deal essentially with the clinical and laboratory diagnosis, clinical care and therapy of patients with these disorders.

Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and (or) applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies.Specifically, of major interest will be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Original research articles, early reports, review articles, commentaries and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome. Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review.

Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers.

Manuscripts should be submitted online at http://ees.elsevier.com/lungcancer and the instructions on this site should be closely followed.

Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. It also provides state-of-the-art Reviews on clinical and experimental therapies in oncology and hematology. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.

Melanoma Research fosters the development of translational research. It promotes the informational exchange between those engaged in the field. The Journal encourages an informed and balanced view of experimental and clinical research, and stimulates the communication and exchange of knowledge between investigators with differing areas of expertise. The Journal presents a coherent and up-to-date account of all aspects of investigations pertinent to melanoma. Consequently, the scope of the Journal is broad, embracing the entire range of studies from fundamental and applied research in such subject areas as genetics, molecular biology, biochemistry, cell biology, photobiology, pathology and immunology, and advances in clinical oncology influencing the prevention, diagnosis and treatment of melanoma. Website: www.melanomaresearch.com.

Molecular Cancer publishes high-quality original research and reviews that present or highlight significant advances in all areas of cancer-related biomedical science.

Molecular Cancer Research publishes original, novel, and well-designed studies on the molecular and cellular aspects of cancer biology. Papers should represent significant new information gathered from basic research that has implications for cancer therapeutics in one of the following areas: Angiogenesis, Metastasis, and the Cellular Microenvironment; Cancer Genes and Genomics; Cell Cycle, Cell Death, and Senescence; DNA Damage and Cellular Stress Responses; Model Organisms; and Signaling and Regulation. All submissions are peer reviewed and only those that meet high standards of scientific merit will be accepted for publication.

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.

Molecular Carcinogenesis presents information describing investigations of molecular aspects of the mechanisms involved in chemical, physical, and viral (biological) carcinogenesis. Areas of interest include, but are not limited to, the structure, expression, or function of genes or gene products associated with normal growth and differentiation and alterations in neoplasia; characterization of genes or gene products expressed in preneoplastic or neoplastic cells; molecular studies that define a specific function of a tumor-associated protein or its effects on cellular function; virtually all research on molecular aspects of oncogenes, tumor suppressor genes, and their gene products; carcinogenesis studies in transgenic mice; and research on human tumor viruses.

Molecular Imaging and Biology presents original research contributions on the utilization of molecular imaging in problems of relevance in biology and medicine. The primary objective of the journal is to provide a forum for the discovery of molecular mechanisms of health and disease through the use of imaging techniques. Among the topics covered are molecular imaging investigations of macromolecular targets involved in significant biological processes; design and evaluation of molecular probes used to investigate macromolecular targets and their functions; and study of in vivo animal models of disease for the development of new molecular diagnostics and therapeutics.The overall goal is to translate basic science discoveries into molecular imaging of disease in patients, both to investigate the biological nature of disease in actual patients and to establish new molecular imaging diagnostic procedures.Molecular Imaging and Biology is the official journal of the World Molecular Imaging Society and the Europea

* Biological Abstracts® (Thomson ISI) * BIOSIS Previews® (Thomson ISI) * Chemical Abstracts Service (CAS) * EMBASE (Elsevier) * Google Scholar * Index Copernicus (IC) * Index Medicus/MEDLINE/PubMed (NLM) * Journal Citation Reports (JCR) Science Edition (Thomson ISI) * Science Citation Index Expanded® (Thomson ISI) * Scopus (Elsevier).

Molecular Omics publishes high-quality research from across the -omics sciences that provide significant new insight into important chemical or biological problems. Topics covered by Molecular Omics include, but are not limited to, proteomics, genomics, transcriptomics, lipidomics, glycomics, metabolomics, microbiomics, sequencing technologies and bioinformatic research. Molecular Omics articles report research that significantly increases understanding or demonstrates clear functional benefits, supported by experimental validation or a novel data analytic approach. Topics include, but are not limited to: -omics studies to gain mechanistic insight into biological processes; -omics studies for clinical applications with experimental validation, such as finding biomarkers for diagnostics or potential new drug targets; -omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques; studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques.